A recombinant rubella virus E1 glycoprotein as a rubella vaccine candidate

Vaccine

Volumn 23, Issue 4, 2004, Pages 480-488

  Perrenoud, G ^a   Messerli, F ^a   Thierry, A C ^a   Beltraminelli, N ^a   Cousin, P ^a   Fasel, N ^b   Vallet, V ^c   Demotz, S ^a   Duchosal, M A ^c   Moulon, C ^a  

^a Ch Vuliette CH 1000 L ^*  (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Recombinant E1 glycoprotein; Rubella virus; Vaccine

Indexed keywords

GLYCOPROTEIN E; NEUTRALIZING ANTIBODY; RECOMBINANT GLYCOPROTEIN E1; RUBELLA ANTIBODY; RUBELLA VACCINE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGENICITY; ARTICLE; CHEMISTRY; CONTROLLED STUDY; DISEASE MODEL; DISEASE SEVERITY; DONOR; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNIZATION; IMMUNOGENICITY; IMPLANTATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RUBELLA; RUBELLA VIRUS; SERUM; TONSIL; VIRUS PARTICLE;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CERCOPITHECUS AETHIOPS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MICE, SCID; NEUTRALIZATION TESTS; RUBELLA; RUBELLA VACCINE; TONSIL; VACCINES, SYNTHETIC; VERO CELLS; VIRAL ENVELOPE PROTEINS;

EID: 7744224035     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.06.030     Document Type: Article

References (23)

1. J.Y. Lee, and D.S. Bowden Rubella virus replication and links to teratogenicity Clin Microbiol. Rev. 13 4 2000 571 587
2. S.A. Plotkin Rubella eradication Vaccine 19 25/26 2001 3311 3319
3. S.W. Bart, H.C. Stetler, S.R. Preblud, N.M. Williams, W.A. Orenstein, and K.J. Bart Fetal risk associated with rubella vaccine: an update Rev. Infect Dis. 7 Suppl 1 1985 S95 S102
4. P. Goon, B. Cohen, L. Jin, R. Watkins, and G. Tudor-Williams MMR vaccine in HIV-infected children-potential hazards? Vaccine 19 28/29 2001 3816 3819
5. J. Nedeljkovic, T. Jovanovic, and C. Oker-Blom Maturation of IgG avidity to individual rubella virus structural proteins J. Clin Virol. 22 1 2001 47 54
6. S.V. Nates, S.E. Mersich, E.B. Damonte, and M.T. Zapata Comparison of immune response to rubella virus proteins in early and late natural infections Microbiologica 12 4 1989 335 338
7. H.H. Chaye, C.A. Mauracher, A.J. Tingle, and S. Gillam Cellular and humoral immune responses to rubella virus structural proteins E1, E2, and C J. Clin Microbiol. 30 9 1992 2323 2329
8. N.O. Seto, and S. Gillam Expression and characterization of a soluble rubella virus E1 envelope protein J. Med. Virol. 44 2 1994 192 199
9. J. Hofmann, S. Gerstenberger, I. Lachmann, C.D. Atreya, and U.G. Liebert Rubella virus nonstructural protein 2 is a minor immunogen Virus Res. 68 2 2000 155 160
10. + T-cell epitope on rubella capsid protein Virology 235 2 1997 286 292
11. E. Bernasconi, N. Fasel, and R. Wittek Cell surface expression of a functional rubella virus E1 glycoprotein by addition of a GPI anchor J. Cell Sci. 109 Pt 6 1996 1195 1201
12. M.A. Duchosal, M.T. Fuzzati-Armentero, R. Baccala, A. Layer, R. Gonzalez-Quintial, and D. Leturcq Human adult tonsil xenotransplantation into SCID mice for studying human immune responses and B cell lymphomagenesis Exp. Hematol. 28 2 2000 177 192
13. J.S. Oxford The growth of rubella virus in small laboratory animals J. Immunol. 98 4 1967 697 701
14. M.G. Cusi, M. Valassina, S. Bianchi, W. Wunner, and P.E. Valensin Evaluation of rubella virus E2 and C proteins in protection against rubella virus in a mouse model Virus Res. 37 3 1995 199 208
15. J. Hofmann, M.W. Pletz, and U.G. Liebert Rubella virus-induced cytopathic effect in vitro is caused by apoptosis J. Gen. Virol. 80 Pt 7 1999 1657 1664
16. L.D. Martinez, and M.T. Zapata Apoptosis induction by the infection with Gilchrist strain of rubella virus J. Clin. Virol. 25 3 2002 309 315
17. G.M. Terry, L. Ho-Terry, P. Londesborough, and K.R. Rees A bio-engineered rubella E1 antigen Arch. Virol. 104 1-2 1989 63 75
18. P. Londesborough, G. Terry, and L. Ho-Terry Reactivity of a recombinant rubella E1 antigen expressed in E. coli Arch. Virol. 122 3/4 1992 391 397
19. T.C. Hobman, M.L. Lundstrom, C.A. Mauracher, L. Woodward, S. Gillam, and M.G. Farquhar Assembly of rubella virus structural proteins into virus-like particles in transfected cells Virology 202 2 1994 574 585
20. W.G. Starkey, J. Newcombe, K.M. Corbett, K.M. Liu, P.G. Sanders, and J.M. Best Use of rubella virus E1 fusion proteins for detection of rubella virus antibodies J. Clin Microbiol. 33 2 1995 270 274
21. T.C. Hobman, M.L. Lundstrom, and S. Gillam Processing and intracellular transport of rubella virus structural proteins in COS cells Virology 178 1 1990 122 133
22. Z. Qiu, F. Tufaro, and S. Gillam The influence of N-linked glycosylation on the antigenicity and immunogenicity of rubella virus E1 glycoprotein Virology 190 2 1992 876 881
23. D. Yang, D. Hwang, Z. Qiu, and S. Gillam Effects of mutations in the rubella virus E1 glycoprotein on E1-E2 interaction and membrane fusion activity J. Virol. 72 11 1998 8747 8755